Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salom é study including 469 patients. A TMRG and GINECO group study

CONCLUSION: Chemotherapy use did not impact survival in the first-line or relapse setting in SCST. Only surgery and its quality demonstrated benefit for PFS in ovarian SCST in any lines of treatment.PMID:37210929 | DOI:10.1016/j.ygyno.2023.05.014

Source: Gynecologic Oncology - May 21, 2023 Category: Cancer & Oncology Authors: Brunhilde Hanvic Fabrice Lecuru H élène Vanacker Patricia Pautier Fabrice Narducci Fran çois Cherifi Anne Floquet Martina Aida Angeles Dominique Berton Christophe Pomel Elsa Kalbacher Magali Provansal Yolanda Fernandez Thibault De La Motte Rouge Cl ém Source Type: research